Yu Heng
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
-
- Thyroid Cancer Diagnosis and Treatment
Papers in
- Oncology 19
- Cancer Immunotherapy and Biomarkers 7
- Inflammatory Biomarkers in Disease Prognosis 6
-
- Head and Neck Cancer Studies 15
- Co-authors
- Lei Tao (36 shared papers)Zheyu Yang (11 shared papers)Xiaoke Zhu (22 shared papers)Liang Zhou (16 shared papers)Wei Cai (10 shared papers)Zhi Yang (6 shared papers)En Xu (5 shared papers)Xingzhou Wang (6 shared papers)
- Journals
- Frontiers in Oncology (3 papers)Frontiers in Endocrinology (3 papers)Journal of Surgical Oncology (2 papers)Oral Oncology (2 papers)Human Cell (2 papers)
- Partner nations
- ChinaOmanUnited States
In The Last Decade
Yu Heng
54 papers receiving 687 citations
Peers
Comparison fields: 5 of 73
- Otorhinolaryngology 63
- Endocrinology, Diabetes and Metabolism 126
- Cancer Research 113
- Oncology 158
- Immunology 90
Countries citing papers authored by Yu Heng
This map shows the geographic impact of Yu Heng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Heng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Heng more than expected).
Fields of papers citing papers by Yu Heng
This network shows the impact of papers produced by Yu Heng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Heng. The network helps show where Yu Heng may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Heng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 100 | |
| 2 | 2021 | 65 | |
| 3 | 2020 | 46 | |
| 4 | 2019 | 41 | |
| 5 | 2021 | 39 | |
| 6 | 2020 | 26 | |
| 7 | 2021 | 24 | |
| 8 | 2020 | 23 | |
| 9 | 2020 | 20 | |
| 10 | Tumor-Infiltrating PD-L1+ Neutrophils Induced by GM-CSF Suppress T Cell Function in Laryngeal Squamous Cell Carcinoma and Predict Unfavorable Prognosis | 2022 | 18 |
| 11 | 2020 | 17 | |
| 12 | 2023 | 17 | |
| 13 | 2022 | 14 | |
| 14 | 2019 | 14 | |
| 15 | 2021 | 14 | |
| 16 | 2019 | 14 | |
| 17 | 2022 | 14 | |
| 18 | 2024 | 12 | |
| 19 | 2021 | 12 | |
| 20 | 2022 | 12 |
About Yu Heng
Yu Heng is a scholar working on Oncology, Otorhinolaryngology, Molecular Biology, Endocrinology, Diabetes and Metabolism and Immunology, having authored 61 papers that have together received 692 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (15 papers), Thyroid Cancer Diagnosis and Treatment (13 papers), Cancer Immunotherapy and Biomarkers (7 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers), Immune Cell Function and Interaction (4 papers), Immune cells in cancer (4 papers), Ferroptosis and cancer prognosis (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Otorhinolaryngology (63 citations), Endocrinology, Diabetes and Metabolism (126 citations), Cancer Research (113 citations), Oncology (158 citations) and Immunology (90 citations). Yu Heng has collaborated with scholars based in China, Oman and United States. Frequent co-authors include Lei Tao, Zheyu Yang, Xiaoke Zhu, Liang Zhou, Wei Cai, Zhi Yang, En Xu, Xingzhou Wang, Liming Lu and Xuefeng Xia. Their work appears in journals such as Frontiers in Oncology, Frontiers in Endocrinology, Journal of Surgical Oncology, Oral Oncology and Human Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.